Mark W. Elrod
Corporate Officer/Principal chez Kowa Pharmaceuticals America, Inc.
Profil
Mark W.
Elrod is currently the SVP-Medical Education & Sales Training at Kowa Pharmaceuticals America, Inc. He previously worked as the Vice President-Sales at Flamel Technologies SA.
Postes actifs de Mark W. Elrod
| Sociétés | Poste | Début |
|---|---|---|
Kowa Pharmaceuticals America, Inc.
 Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Corporate Officer/Principal | - |
Anciens postes connus de Mark W. Elrod
| Sociétés | Poste | Fin |
|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Sales & Marketing | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Health Technology |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
